282 related articles for article (PubMed ID: 23807661)
1. Prognostic value of early postoperative tumor marker response in gastric cancer.
Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
[TBL] [Abstract][Full Text] [Related]
2. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
4. Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.
Komatsu S; Ichikawa D; Nishimura Y; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Anticancer Res; 2013 Apr; 33(4):1621-7. PubMed ID: 23564806
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
Li Y; Yang Y; Lu M; Shen L
Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
[TBL] [Abstract][Full Text] [Related]
8. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697
[TBL] [Abstract][Full Text] [Related]
9. Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer.
Zhang Q; Qu H; Sun G; Li Z; Ma S; Shi Z; Zhao E; Zhang H; He Q
Medicine (Baltimore); 2017 Aug; 96(32):e7560. PubMed ID: 28796039
[TBL] [Abstract][Full Text] [Related]
10. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.
Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB
J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055
[TBL] [Abstract][Full Text] [Related]
11. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
15. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
Dilege E; Mihmanli M; Demir U; Ozer K; Bostanci O; Kaya C; Aksakal O; Sakiz D
Hepatogastroenterology; 2010; 57(99-100):674-7. PubMed ID: 20698248
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.
Kwon OK; Yu W; Chung H
Hepatogastroenterology; 2013; 60(122):240-3. PubMed ID: 22975648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]